Source: Nutrients. Unidade: FMRP
Subjects: CÉLULAS ENDOTELIAIS, INSUFICIÊNCIA RENAL CRÔNICA, DIFERENCIAÇÃO CELULAR, TRANSDUÇÃO DE SINAL CELULAR
ABNT
DELUQUE, Amanda Lima et al. Paricalcitol improves the angiopoietin/tie-2 and VEGF/VEGFR2 signaling pathways in adriamycin-induced nephropathy. Nutrients, v. 14, n. 24, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3390/nu14245316. Acesso em: 12 set. 2024.APA
Deluque, A. L., Oliveira, B. M., Souza, C. S., Maciel, A. L. D., Francescato, H. D. C., Giovanini, C., et al. (2022). Paricalcitol improves the angiopoietin/tie-2 and VEGF/VEGFR2 signaling pathways in adriamycin-induced nephropathy. Nutrients, 14( 24), 1-19. doi:10.3390/nu14245316NLM
Deluque AL, Oliveira BM, Souza CS, Maciel ALD, Francescato HDC, Giovanini C, Almeida LF de, Paula FJA de, Costa RS, Antunes-Rodrigues J, Coimbra TM. Paricalcitol improves the angiopoietin/tie-2 and VEGF/VEGFR2 signaling pathways in adriamycin-induced nephropathy [Internet]. Nutrients. 2022 ; 14( 24): 1-19.[citado 2024 set. 12 ] Available from: https://doi.org/10.3390/nu14245316Vancouver
Deluque AL, Oliveira BM, Souza CS, Maciel ALD, Francescato HDC, Giovanini C, Almeida LF de, Paula FJA de, Costa RS, Antunes-Rodrigues J, Coimbra TM. Paricalcitol improves the angiopoietin/tie-2 and VEGF/VEGFR2 signaling pathways in adriamycin-induced nephropathy [Internet]. Nutrients. 2022 ; 14( 24): 1-19.[citado 2024 set. 12 ] Available from: https://doi.org/10.3390/nu14245316